RONCATO, ROSSANA

RONCATO, ROSSANA  

Dipartimento di Medicina - DIMED  

Mostra records
Risultati 1 - 18 di 18 (tempo di esecuzione: 0.031 secondi).
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
Clinical validity of a DPYD-based pharmacogenetic test to predict severe toxicity to fluoropyrimidines 2015 GIODINI, LUCIANARONCATO, ROSSANAGAGNO, SARA + INTERNATIONAL JOURNAL OF CANCER - -
Pregnane X receptor, constitutive androstane receptor and hepatocyte nuclear factors as emerging players in cancer precision medicine 2016 RONCATO, ROSSANA + PHARMACOGENOMICS - -
Cost evaluation of irinotecan-related toxicities associated with the UGT1A1*28 patient genotype 2017 RONCATO, ROSSANAGIODINI, LUCIANA + CLINICAL PHARMACOLOGY & THERAPEUTICS - -
Genetic biomarkers for hepatocellular cancer risk in a caucasian population. 2017 Cecchin EBignucolo ARoncato R + WORLD JOURNAL OF GASTROENTEROLOGY - -
Pharmacogenomics of targeted agents for personalization of colorectal cancer treatment 2017 Bignucolo A.Cecchin E.Roncato R. + INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - -
Innovative strategies for tailoring therapy in cancer patient pharmacogenetics and therapy personalization in metastatic colorectal cancer patients treated with irinotecan 2017 Roncato, Rossana - - -
DEVELOPMENT OF AN INTEGRATED HEALTH IT PLATFORM FOR A PRECISE AND COST-EFFECTIVE THERAPY IN ONCOLOGY 2018 Roncato, RBignucolo, AToffoli, GCecchin, E + BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY - -
Association of STAT-3 rs1053004 and VDR rs11574077 With FOLFIRI-related gastrointestinal toxicity in metastatic colorectal cancer patients 2018 Cecchin E.Roncato R.Bignucolo A. + FRONTIERS IN PHARMACOLOGY - -
The Genotype for DPYD Risk Variants in Patients With Colorectal Cancer and the Related Toxicity Management Costs in Clinical Practice 2018 ECCA, FABIOBignucolo A.Roncato R.Cecchin E. + CLINICAL PHARMACOLOGY & THERAPEUTICS - -
Development of an Integrated Health IT Platform for a Precision Medicine Setting 2018 Roncato, RBignucolo, AToffoli, GCecchin, E + PUBLIC HEALTH GENOMICS - -
Germline Polymorphisms in the Nuclear Receptors PXR and VDR as Novel Prognostic Markers in Metastatic Colorectal Cancer Patients Treated With FOLFIRI 2019 Roncato R.Bignucolo A. + FRONTIERS IN ONCOLOGY - -
PREEMPTIVE PHARMACOGENOMIC TESTING FOR PREVENTING ADVERSE DRUG REACTIONS (PREPARE): STATE OF ART AND PRELIMINARY RESULTS ON GENOTYPE ACTIONABILITY 2019 Alessia BignucoloSilvia MezzaliraRossana RoncatoFabio PuglisiGiuseppe Toffoli + - - PERSONALIZED MEDICINE
FARMAPRICE: A Pharmacogenetic Clinical decision support system for precise and Cost-Effective Therapy 2019 Roncato R.Bignucolo A.Cecchin E. + GENES - -
A TGF-β associated genetic score to define prognosis and platinum sensitivity in advanced epithelial ovarian cancer 2020 Gagno S.Poletto E.Romualdi C.Roncato R. + GYNECOLOGIC ONCOLOGY - -
Pharmacogenetic score predicts overall survival, progression-free survival and platinum sensitivity in ovarian cancer 2020 Romualdi, ChiaraRoncato, Rossana + PHARMACOGENOMICS - -
Il15ra and smad3 genetic variants predict overall survival in metastatic colorectal cancer patients treated with folfiri therapy: A new paradigm 2021 Roncato R.Bignucolo A.Gagno S.Cecchin E.Toffoli G. + CANCERS - -
Therapeutic drug monitoring for the cancer patient: challenges and opportunities 2021 Poetto, AS.Roncato, R. + PHARMADVANCES - -
SMAD3 Host and Tumor Profiling to Identify Locally Advanced Rectal Cancer Patients at High Risk of Poor Response to Neoadjuvant Chemoradiotherapy 2021 Roncato, RossanaBignucolo, AlessiaBelluco, ClaudioPucciarelli, Salvatore + FRONTIERS IN PHARMACOLOGY - -